Sponsored by
The complaint of lower urinary tract symptoms (LUTS) is a common problem among elderly men. They include a variety of storage, voiding and post-micturition symptoms indicative of lover urinary tract dysfunction. The presence of LUTS in older men is commonly attributed to Benign prostatic hyperplasia (BPH). Benign Prostatic Hyperplasia (BPH) is a one of the most common diseases among the older men in Singapore, especially men who aged 40 or above. BPH affects men as they age, with almost half of men over 50 developing symptoms. While BPH is benign, delays in symptoms management or treatment may lead to complications like urinary infections, kidney failure or bladder outlet obstruction. The presence of LUTS often results in a poor quality of life (QOL). LUTS have been shown to have negative impact on work productivity, libido, and emotional well-being. However, despite relatively high reported levels of bother, many men with moderate-to-severe LUTS still do not seek medical advice for their symptoms. This lunch talk seeks to give an overview about LUTS/BPH symptoms, the importance on bladder, the therapies of BPH with the preservation of sexual function as well as questions and answers.
Our Speakers
Dr. Ronny Tan
Urologist
Dr. Ronny Tan Ban Wei is a Consultant Urologist and Andrologist who is trained locally, board certified by the Specialist Accreditation Board and fellowship-trained in Andrology, Male Subfertilty, Sexual Medicine and Urological Prosthetic Surgery. He is the first Singaporean to undergo a clinical fellowship in USA in this niche specialty.
During his fellowship, Dr. Tan was trained in the placement of urethral slings, artificial urinary sphincters and penile prosthesis (both malleable and inflatable) using the Coloplast and Boston Scientific AMS systems.
Dr Tan is proficient in single-incision concomitant placement of prostheses for both erectile dysfunction and stress urinary incontinence. He was one of the first to use intralesional injections to treat Peyronie’s disease and reported on the efficacy of second generation PDE5 inhibitors for treating erectile dysfunction. He had the privilege of performing prostatic urethral lift using the novel Urolift system while on fellowship. Prior to starting private practice, Dr. Tan was Director of Andrology in Tan Tock Seng Hospital (TTSH) and helmed the Complex Erectile Dysfunction Clinic. He pioneered the use of low-intensity extracorporeal shockwave therapy (LiESWT) for erectile dysfunction in restructured hospitals. For the treatment of BPH, Dr. Tan offers TURP, TUVP (greenlight laser) and minimally invasive treatment including Urolift. He placed the first Urolift implant in Singapore on October 16, 2019.
Dr. Tan is experienced in treating penile deformities ranging from frenulum brevie to congenital penile curvatures to Peyronie’s disease. He offers evaluation for male subfertility and is trained in sperm retrieval techniques ranging from percutaneous sperm aspiration, microsurgical TESE to electro-ejaculation. He offers microsurgical varicocelectomy for treatment of varicoceles.
Dr. Tan served as Clinical Core Faculty of the NHG Urology Residency Program, trained many urology specialists and was awarded “Best Teacher” for his passion and dedication for teaching. He is an Adjunct Assistant Professor of the Lee Kong Chian School of Medicine, Nanyang Technological University and a Senior Lecturer of the Yong Loo Lin School of Medicine, National University of Singapore. He is a regular reviewer for the Journal of Sexual Medicine, Sexual Medicine Reviews and Urology (Gold Journal). He has also served as Course Director in numerous symposiums, masterclasses and courses on andrology and sexual medicine. Dr Tan is often invited as Speaker and faculty of loco-regional and international conferences.
He was awarded the coveted Gold Award at the Asian Hospital Management Awards 2018 for cost-effective ambulatory day surgical management of patients in TTSH who underwent TURP/TUVP. He was on the Committee for Clinical Practice Guidelines 2012 for treatment of Premature Ejaculation and was Co-chairman for the SMHS Guidelines 2014 for management of erectile dysfunction. He was awarded the Youth Fellowship of the Urological Association of Urology in 2017 and is currently on the Executive Committee of the Singapore Urological Association. He serves as Vice President of the Society for Men’s Health Singapore, is Honorary Secretary of the Society for Continence Singapore, Vice-President of the Global Chinese Andrology and Sexual Medicine Association as well as Chairman of the Membership Committee of the International Society for Sexual Medicine.
Dr. Chong Kian Tai
Urologist
Dr. Chong Kian Tai (张建泰医生) is a certified Urologist who manages both General Urology and complex Urologic Cancers. He is a Specialist Urology Surgeon who is skilled in working with different treatment choices for optimal outcome. Treatments he is proficient in include traditional open surgery, advanced keyhole laparoscopic and endoscopic surgery, as well as the modern da Vinci Robotic Surgical Systems.
Dr. Chong completed his full-time advanced Clinical Urologic-Oncology Fellowship at the prestigious Memorial Sloan Kettering Cancer Center in New York, U.S. in 2009. His key professional expertise includes the diagnosis, treatment and management of prostate, kidney, bladder, testis and penile cancers.
For Urologic Cancers, Dr. Chong focuses on the following:
For General Urology, Dr. Chong focuses on the following:
1. Enlarged prostate, also known as BPH (benign prostate hyperplasia)
– New procedures that are less invasive than traditional resection surgery. Examples include the UroLift, Rezum and Prolieve procedures.
2. Retrograde intrarenal surgery (RIRS)
– Uses flexible ureteroscope to treat small kidney stones by laser stone surgery. There is no cutting and no surgical scars on the skin.
Prior to private practice, Dr. Chong was the Consultant, Adjunct Assistant Professor, Co-Director of Urologic Oncology and Director of Research in the Department of Urology at Tan Tock Seng Hospital (TTSH). He also managed the Urology Cancer clinical databases and tissue repository. In the Singapore Cancer Society, he was an Advisory Panel member to improve prostate cancer awareness and survivorship.
Dr. Chong is a dynamic healthcare innovator, researcher and educator. He started molecular research in Urologic-Oncology on prostate cancer immunology at Seattle, Washington, U.S., which was funded by Southwest Oncology Group (SWOG) and Agency for Science, Technology and Research (A*STAR). While in Singapore, he was a founding member of the Singapore Urological Cancer Consortium and had been in-charge of several teams in prostate, kidney, bladder and testis cancer research. These projects included precision medicine, biomolecular, nanoparticle, bioimaging and novel biomedical device studies.
To improve holistic care for urological cancer patients in TTSH, Dr. Chong was Chairman for the Urology Cancer Multidisciplinary Tumour Board, Chairman for Urology Cancer Support Programme, Chairman for Advanced Care Planning Team and Chairman for TTSH Prostate Cancer Support Group involving cancer patients and their family.
Dr. Chong's specialty interests are bladder cystoscopy and narrow-band imaging, da vinci robotic partial nephrectomy, da vinci robotic radical prostatectomy, MRI ultrasound fusion prostate bipsy and retrograde intrarenal surgery.
